With over 55 products in 9 therapeutic areas, Alfasigma is a key player in the Italian pharmaceutical industry, boasting a portfolio ranging from prescription specialties and over-the-counter products all the way to nutraceuticals.
In Italy, it is a market leader for prescription drugs, boasting a presence in many primary care therapeutic areas (gastroenterology, vascular and diabetes, cardiology, orthopaedics and rheumatology, broncho-pneumology), as well as for well-known over-the-counter products such as Biochetase, Neo-Borocillin, Dicloreum and Yovis.
Worldwide, Alfasigma has products in the following therapeutic areas.